Severe phototoxicity associated with concomitant use of methotrexate and voriconazole, an overlooked drug‐drug interaction-Reference-Cited by-同舟云学术

Severe phototoxicity associated with concomitant use of methotrexate and voriconazole, an overlooked drug‐drug interaction

Published:2020-03-24 Issue:6 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Bogaert Delfien J.¹²^ORCID,Verlinden Louisa³,Vandecruys Els⁴,Laureys Geneviève⁴,Verhaeghe Evelien³,Bauters Tiene⁴⁵^ORCID

Affiliation:

1. Primary Immunodeficiency Research LabCenter for Primary Immunodeficiency GhentJeffrey Modell Diagnosis and Research CenterGhent University Hospital Ghent Belgium

2. Department of PediatricsGhent University Hospital Ghent Belgium

3. Department of DermatologyGhent University Hospital Ghent Belgium

4. Department of PediatricsDivision of Pediatric Hemato‐Oncology and Stem Cell TransplantationGhent University Hospital Ghent Belgium

5. Department of PharmacyGhent University Hospital Ghent Belgium

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28246

Reference12 articles.

1. Voriconazole phototoxicity in children: A retrospective review

2. Drug-induced phototoxicity: A systematic review

3. Recurrent recall of sunburn by methotrexate

4. Methotrexate sodium‐associated UV reactivation in a patient with acute lymphoblastic leukemia;Yankura J;Cutis,2012

5. Ultraviolet recall reaction after total body irradiation, etoposide, and methotrexate therapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel drug-drug interactions prediction method based on a graph attention network;Electronic Research Archive;2023

2. Voriconazole injection may induce delayed methotrexate excretion: a case report and experimental study;Journal of Pharmaceutical Health Care and Sciences;2022-03-26

3. Antifungal Drugs TDM: Trends and Update;Therapeutic Drug Monitoring;2022-02